KAYEXALATE Side Effects

6987135-4 | Angioedema
on Sep 08, 2010 Male patient from FRANCE , 37 years of age, weighting 136.7 lb, was treated with Kayexalate (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema. Kayexalate dosage: . During the same period patient was treated with DECTANCYL (View Dectancyl Review and Dectancyl Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ESIDRIX (View Esidrix Review and Esidrix Label ), VITAMIN B1 AND B6 (View Vitamin B1 And B6 Review and Vitamin B1 And B6 Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), NIDREL (View Nidrel Review and Nidrel Label ), MEDIATENSYL (View Mediatensyl Review and Mediatensyl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6588695-8 | Thrombocytopenia
Patient was taking Kayexalate (View Usage). Patient had the following side effects: thrombocytopenia on Feb 08, 2010 from FRANCE Additional patient health information: Female patient , 67 years of age, was diagnosed with pulmonary embolism (What is pulmonary embolism?), gastroduodenal ulcer and. Kayexalate dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ), PREVISCAN (View Previscan Review and Previscan Label ), NOVONORM (View Novonorm Review and Novonorm Label ), PLAVIX (View Plavix Review and Plavix Label ), FLUTICASONE PROPIONATE/SALMETEROL (View Fluticasone Propionate/salmeterol Review and Fluticasone Propionate/salmeterol Label ). Patient was hospitalized.

5787762-6 | No Adverse Event
Adverse event was reported on Jun 24, 2008 by a Male patient taking Kayexalate (View Usage) (Dosage: 60 Grams Time 1 Po) was diagnosed with hyperkalaemia and. Location: UNITED STATES , weighting 142.9 lb, After Kayexalate was administered, patient had the following side effects: no adverse event. During the same period patient was treated with ALBUTEROL (1 Inhalation Times 4 Inhal) (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

5786029-X | No Adverse Event
on Jun 20, 2008 Male patient from UNITED STATES , 71 years of age, weighting 142.9 lb, was diagnosed with hyperkalaemia and was treated with Kayexalate (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event. Kayexalate dosage: 60 Grams 1 Time Po. Patient was hospitalized.


5511128-7 | Gastrointestinal Necrosis, Intestinal Ischaemia, Large Intestine Perforation
on Oct 31, 2007 Male patient from UNITED STATES , 39 years of age, was diagnosed with hyperkalaemia and was treated with Kayexalate (View Usage). Patient had the following side effects: gastrointestinal necrosis, intestinal ischaemia, large intestine perforation. Kayexalate dosage: . During the same period patient was treated with SORBITOL (View Sorbitol Review and Sorbitol Label ).

5389989-4 | Gastrointestinal Necrosis, Haematochezia, Intestinal Ischaemia, Large Intestine Perforation
Patient was taking Kayexalate (View Usage). After Kayexalate was administered, patient had the following side effects: gastrointestinal necrosis, haematochezia, intestinal ischaemia, large intestine perforation on Jun 29, 2007 from UNITED STATES Additional patient health information: Female patient , 71 years of age, . Kayexalate dosage: Unk. Patient was hospitalized.

5383261-4 | Foreign Body Trauma, Rectal Stenosis
Adverse event was reported on Jun 28, 2007 by a Male patient taking Kayexalate (View Usage) (Dosage: 30 G) was diagnosed with hyperkalaemia and. Location: FRANCE , 46 years of age, Patient experienced the following unwanted or unexpected effects: foreign body trauma, rectal stenosis.

5375035-5 | Gastrointestinal Necrosis, Haematochezia, Intestinal Ischaemia, Large Intestine Perforation
on Jun 19, 2007 Female patient from UNITED STATES , 71 years of age, was treated with Kayexalate (View Usage). Patient had the following side effects: gastrointestinal necrosis, haematochezia, intestinal ischaemia, large intestine perforation. Kayexalate dosage: Unk. Patient was hospitalized.

5373718-4 | Foreign Body Trauma, Rectal Stenosis
on Jun 18, 2007 Male patient from FRANCE , 46 years of age, was diagnosed with renal failure and was treated with Kayexalate (View Usage). After Kayexalate was administered, patient had the following side effects: foreign body trauma, rectal stenosis. Kayexalate dosage: Unk.

5262722-2 | Hypocalcaemia, Hypokalaemia, Rhabdomyolysis
Patient was taking Kayexalate (View Usage). Patient experienced the following unwanted or unexpected effects: hypocalcaemia, hypokalaemia, rhabdomyolysis on Mar 08, 2007 from JAPAN Additional patient health information: Female patient , 70 years of age, . Kayexalate dosage: .

5241774-X | Intravascular Haemolysis
Adverse event was reported on Feb 07, 2007 by a Female patient taking Kayexalate (View Usage) (Dosage: ) . Location: FRANCE , 64 years of age, Patient had the following side effects: intravascular haemolysis. During the same period patient was treated with VENOFER (Unk) (View Venofer Review and Venofer Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), ORACILLINE (Unk) (View Oracilline Review and Oracilline Label ), LEXOMIL (Unk) (View Lexomil Review and Lexomil Label ), OROCAL (2 G) (View Orocal Review and Orocal Label ), COUMADIN (View Coumadin Review and Coumadin Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), MIMPARA (View Mimpara Review and Mimpara Label ). Patient was hospitalized.

5162932-9 | Colitis Ischaemic, Fungal Infection, Gastrointestinal Necrosis, Haemoglobin Decreased, Large Intestine Perforation, Multi-organ Failure, Peritoneal Haemorrhage, Pseudomonas Infection, Septic Shock
on Sep 05, 2002 Male patient from FRANCE , weighting 114.6 lb, was diagnosed with hyperkalaemia and was treated with Kayexalate (View Usage). After Kayexalate was administered, patient had the following side effects: colitis ischaemic, fungal infection (What is fungal infection?), gastrointestinal necrosis, haemoglobin decreased, large intestine perforation, multi-organ failure, peritoneal haemorrhage, pseudomonas infection, septic shock. Kayexalate dosage: . During the same period patient was treated with HYDROXIDE D'ALUMINE (2 G) (View Hydroxide D'alumine Review and Hydroxide D'alumine Label ), NOCTRAN (20 Mg) (View Noctran Review and Noctran Label ), BRONILIDE (4 Unit) (View Bronilide Review and Bronilide Label ), SEREVENT (4 Unit) (View Serevent Review and Serevent Label ), ATARAX (100 Mg) (View Atarax Review and Atarax Label ), MEDROL (12 Mg) (View Medrol Review and Medrol Label ). Patient was hospitalized.

5097393-1 | Aspiration
on Aug 25, 2006 Male patient from UNITED STATES , 58 years of age, was diagnosed with hyperkalaemia and was treated with Kayexalate (View Usage). Patient experienced the following unwanted or unexpected effects: aspiration. Kayexalate dosage: Unk.

4855890-5 | Blood Pressure Increased, Fatigue, Hypertension, Oedema Peripheral
Patient was taking Kayexalate (View Usage). Patient had the following side effects: blood pressure increased, fatigue, hypertension, oedema peripheral on Nov 10, 2005 from FRANCE Additional patient health information: Female patient , 74 years of age, was diagnosed with hyperkalaemia and. Kayexalate dosage: . During the same period patient was treated with TENORMIN (Unk) (View Tenormin Review and Tenormin Label ), ATACAND (Unk) (View Atacand Review and Atacand Label ).

4835951-7 | Blood Pressure Increased
Adverse event was reported on Nov 10, 2005 by a Female patient taking Kayexalate (View Usage) (Dosage: 45 G) . Location: FRANCE , 74 years of age, After Kayexalate was administered, patient had the following side effects: blood pressure increased. During the same period patient was treated with LASILIX (Unk) (View Lasilix Review and Lasilix Label ), TENORMIN (Unk) (View Tenormin Review and Tenormin Label ), ATACAND (Unk) (View Atacand Review and Atacand Label ).

4718543-X | Hypomania
on May 08, 2000 Male patient from BELGIUM , weighting 196.2 lb, was diagnosed with hyperkalaemia, bipolar disorder (What is bipolar disorder?), diabetes mellitus and was treated with Kayexalate (View Usage). Patient experienced the following unwanted or unexpected effects: hypomania. Kayexalate dosage: . During the same period patient was treated with MANIPREX (350 Mg) (View Maniprex Review and Maniprex Label ), DEPAKENE (1800 Mg) (View Depakene Review and Depakene Label ), AMILORIDE HCL (20 Mg) (View Amiloride Hcl Review and Amiloride Hcl Label ), HYGROTON (50 Mg) (View Hygroton Review and Hygroton Label ), HALDOL DECANOAS (100 Mg) (View Haldol Decanoas Review and Haldol Decanoas Label ), KEMADRIN (Unk) (View Kemadrin Review and Kemadrin Label ).

4713382-8 | Hypomania
on May 08, 2000 Male patient from BELGIUM , weighting 196.2 lb, was diagnosed with hyperkalaemia, bipolar disorder (What is bipolar disorder?), diabetes mellitus and was treated with Kayexalate (View Usage). Patient had the following side effects: hypomania. Kayexalate dosage: . During the same period patient was treated with MANIPREX (350 Mg) (View Maniprex Review and Maniprex Label ), DEPAKENE (1800 Mg) (View Depakene Review and Depakene Label ), AMILORIDE HCL (20 Mg) (View Amiloride Hcl Review and Amiloride Hcl Label ), HYGROTON (50 Mg) (View Hygroton Review and Hygroton Label ), HALDOL DECANOAS (100 Mg) (View Haldol Decanoas Review and Haldol Decanoas Label ), KEMADRIN (Unk) (View Kemadrin Review and Kemadrin Label ).

4706593-9 | Colonic Stenosis, Constipation, Enterocolitis, Intestinal Obstruction, Large Intestine Perforation, Melaena, Peritonitis
Patient was taking Kayexalate (View Usage). After Kayexalate was administered, patient had the following side effects: colonic stenosis, constipation (What is constipation?), enterocolitis, intestinal obstruction, large intestine perforation, melaena, peritonitis on Jun 21, 2005 from JAPAN Additional patient health information: Female patient , 68 years of age, was diagnosed with hyperkalaemia, abdominal pain (What is abdominal pain?), constipation (What is constipation?), back pain (What is back pain?), arthralgia and. Kayexalate dosage: Unk. During the same period patient was treated with KALIMATE (Unk) (View Kalimate Review and Kalimate Label ), CRAVIT (Unk) (View Cravit Review and Cravit Label ), PURSENNID (Unk) (View Pursennid Review and Pursennid Label ), LOXONIN (Unk) (View Loxonin Review and Loxonin Label ), D SORBITOL (Unk) (View D-sorbitol Review and D-sorbitol Label ). Patient was hospitalized.

4705082-5 | Large Intestine Perforation, Melaena, Peritonitis
Adverse event was reported on Jun 21, 2005 by a Female patient taking Kayexalate (View Usage) (Dosage: Unk) was diagnosed with hyperkalaemia, abdominal pain (What is abdominal pain?), constipation (What is constipation?), back pain (What is back pain?), arthralgia and. Location: JAPAN , 68 years of age, Patient experienced the following unwanted or unexpected effects: large intestine perforation, melaena, peritonitis. During the same period patient was treated with KALIMATE (Unk) (View Kalimate Review and Kalimate Label ), CRAVIT (Unk) (View Cravit Review and Cravit Label ), PURSENNID (Unk) (View Pursennid Review and Pursennid Label ), LOXONIN (Unk) (View Loxonin Review and Loxonin Label ), D SORBITOL (Unk) (View D-sorbitol Review and D-sorbitol Label ). Patient was hospitalized.

4614633-0 | Abdominal Distension, Diarrhoea, Gastrointestinal Necrosis
on Nov 22, 2004 Male patient from , 79 years of age, was diagnosed with hyperkalaemia and was treated with Kayexalate (View Usage). Patient had the following side effects: abdominal distension, diarrhoea, gastrointestinal necrosis. Kayexalate dosage: 2 Doses Of 60 G Each, One In Afternoon And One That Night - Oral. During the same period patient was treated with SORBITOL (One Dose In Afternoon And One That Night) (View Sorbitol Review and Sorbitol Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), TRIAMCINOLONE (View Triamcinolone Review and Triamcinolone Label ), WARFARIN (View Warfarin Review and Warfarin Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ). Patient was hospitalized.

4613577-8 | Colitis Ischaemic
on Mar 01, 2005 Female patient from , 63 years of age, was treated with Kayexalate (View Usage). After Kayexalate was administered, patient had the following side effects: colitis ischaemic. Kayexalate dosage: 15 G Qid; Oral. Patient was hospitalized.

4613576-6 | Colitis Ischaemic, Gastrointestinal Disorder, Haemodynamic Instability, Necrosis Ischaemic, Rectal Haemorrhage
Patient was taking Kayexalate (View Usage). Patient experienced the following unwanted or unexpected effects: colitis ischaemic, gastrointestinal disorder, haemodynamic instability, necrosis ischaemic, rectal haemorrhage on Mar 01, 2005 from Additional patient health information: Male patient , 70 years of age, . Kayexalate dosage: Rectal. Patient was hospitalized.

4603149-3 | Colitis Ulcerative, Diarrhoea, Escherichia Infection, Graft Versus Host Disease, Liver Disorder, Lung Disorder, Rectal Haemorrhage, Thrombotic Microangiopathy
Adverse event was reported on Feb 17, 2005 by a Male patient taking Kayexalate (View Usage) (Dosage: Oral) . Location: , 42 years of age, Patient had the following side effects: colitis ulcerative, diarrhoea, escherichia infection, graft versus host disease, liver disorder, lung disorder, rectal haemorrhage, thrombotic microangiopathy. During the same period patient was treated with NEORAL (View Neoral Review and Neoral Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), BACTRIM (SULFAMETHOXAZOLE, TRIMETHOPRIME) (View Bactrim (sulfamethoxazole, Trimethoprime) Review and Bactrim (sulfamethoxazole, Trimethoprime) Label ), ORACILLINE (PHENOXYMETHYLENICILLIN) (View Oracilline (phenoxymethylenicillin) Review and Oracilline (phenoxymethylenicillin) Label ), VALACYCLOVIR HCL (View Valacyclovir Hcl Review and Valacyclovir Hcl Label ), LEDERFOLINE (CALCIUM FOLINATE) (View Lederfoline (calcium Folinate) Review and Lederfoline (calcium Folinate) Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CORTICOIDS NOS (View Corticoids Nos Review and Corticoids Nos Label ). Patient was hospitalized.

4591297-6 | Aspiration, Cardiomegaly, Coma, Intercapillary Glomerulosclerosis, Pulmonary Congestion, Pulmonary Oedema
on Feb 03, 2005 Female patient from , 63 years of age, was diagnosed with hyperkalaemia and was treated with Kayexalate (View Usage). After Kayexalate was administered, patient had the following side effects: aspiration, cardiomegaly, coma, intercapillary glomerulosclerosis, pulmonary congestion, pulmonary oedema. Kayexalate dosage: .